You are here: Industry Insights > Pfizer

News List

Pfizer and BioNTech begin Covid-19 vaccine trial in pregnant women pharmaceutical-technology
February 20, 2021
Pfizer and BioNTech have dosed the first participants in a global Phase II / III study of their vaccine in preventing Covid-19 in healthy pregnant women aged 18 and above.
South African variant may weaken vaccine protection: Pfizer expresspharma
February 20, 2021
The study found the vaccine was still able to neutralise the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said.
250mn Europeans to be vaccinated with COMIRNATY® by the end of 2021 europeanpharmaceuticalreview
February 19, 2021
Pfizer and BioNTech have agreed to supply the European Union with 200 million additional doses of COMIRNATY in 2021, making the total 500 million doses.
Pfizer-BioNTech’s Covid-19 vaccine-immunised sera neutralises SA variant pharmaceutical-technology
February 18, 2021
Pfizer and BioNTech have reported results from an in vitro study, which showed the capability of sera from individuals immunised with their Covid-19 vaccine (BNT162b2) in neutralising SARS-CoV-2 with the South African variant spike protein.
Research reveals Pfizer-BioNTech COVID-19 vaccine elicits strong immune response with single dose expresspharma
February 18, 2021
The response among those previously infected was so effective that it opens the debate as to whether one dose of the vaccine may suffice, the researchers said.
S Sridhar elected as President of OPPI expresspharma
February 18, 2021
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President. The term is for a period of two years and is effective from February 15, 2021.
Pfizer gets US FDA approval for PANZYGA to treat chronic inflammatory demyelinating polyneuropathy expresspharma
February 18, 2021
t is the only FDA-approved intravenous immunoglobulin with two maintenance dosing options for CIDP.
Pfizer's 4Q Revenues up 12% contractpharma
February 10, 2021
COVID-19 vaccine BNT162b2, which was granted an EUA in the U.S. in December 2020, contributed $154 million in sales in the quarter.
UK launches trial to study alternating COVID-19 vaccines for different doses europeanpharmaceuticalreview
February 07, 2021
The UK Government has given £7 million of funding for a clinical trial which will investigate whether patients can be given different COVID-19 vaccines for each dose.
Pfizer drops India vaccine application after regulator seeks local trial expresspharma
February 07, 2021
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page